Efficient Inhibition of Ovarian Cancer by Degradable Nanoparticle-Delivered Survivin T34A Gene [Corrigendum]
Luo L, Du T, Zhang J, et al. Int J Nanomedicine. 2016;11:501—513. The authors have advised due to an error at the time of figure assembly, Figure 11 on page 510 is incorrect. The correct Figure 11 is shown below. The authors apologize for this error and advise it...
Guardado en:
Autores principales: | Luo L, Du T, Zhang J, Zhao W, Cheng H, Yang Y, Wu Y, Wang C, Men K, Gou M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e50a38bf6e04b6fa0ef317d50e6f806 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene
por: Luo L, et al.
Publicado: (2016) -
Wild type, dEX3 and 2B survivin isoforms localize to the tumor cell plasma membrane, are secreted in exosomes, and interact with extracellular tubulin
por: Sheila Figel, et al.
Publicado: (2021) -
Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7
por: Bi YZ, et al.
Publicado: (2016) -
Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy
por: Maria Arista-Romero, et al.
Publicado: (2021) -
Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
por: Bi Y, et al.
Publicado: (2018)